 |
|
|
|||||
National Commodity and Derivatives Exchange's unlisted shares are experiencing a significant surge. This increase follows Securities and Exchange Board of India's approval for equity products. Investments from prominent figures like Radhakishan Damani and Groww are fueling the rally. NCDEX plans to launch equity and equity derivatives products. Experts predict further price increases after the launch.
Category:
News and Media
VMS TMT's Rs 149 crore IPO has garnered significant investor interest, with an overall subscription of 12.49 times on its second day, driven by strong NII participation. The IPO shares are trading at a 17% premium in the grey market, reflecting positive market sentiment. Proceeds from the IPO will be used to repay borrowings and for general corporate purposes.
Category:
News and Media
Shares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab biosimilars, Bosaya and Aukelso. The regulator also granted provisional interchangeability for both drugs, allowing pharmacy-level substitution, which could support broader market adoption and strengthen Biocons position in the biosimilars segment.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||